- Home
- KSCP vs SHLT Comparison
KSCP vs SHLT Comparison
Compare KSCP & SHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSCP
- SHLT
- Stock Information
- Founded
- KSCP 2013
- SHLT 1987
- Country
- KSCP United States
- SHLT Israel
- Employees
- KSCP N/A
- SHLT N/A
- Industry
- KSCP Telecommunications Equipment
- SHLT Business Services
- Sector
- KSCP Telecommunications
- SHLT Consumer Discretionary
- Exchange
- KSCP Nasdaq
- SHLT Nasdaq
- Market Cap
- KSCP N/A
- SHLT 39.3M
- IPO Year
- KSCP 2022
- SHLT N/A
- Fundamental
- Price
- KSCP $2.82
- SHLT $2.07
- Analyst Decision
- KSCP Strong Buy
- SHLT
- Analyst Count
- KSCP 1
- SHLT 0
- Target Price
- KSCP $16.00
- SHLT N/A
- AVG Volume (30 Days)
- KSCP 262.9K
- SHLT 7.7K
- Earning Date
- KSCP 05-15-2025
- SHLT 04-24-2025
- Dividend Yield
- KSCP N/A
- SHLT N/A
- EPS Growth
- KSCP N/A
- SHLT N/A
- EPS
- KSCP N/A
- SHLT N/A
- Revenue
- KSCP $11,005,000.00
- SHLT $55,939,000.00
- Revenue This Year
- KSCP N/A
- SHLT N/A
- Revenue Next Year
- KSCP $19.53
- SHLT N/A
- P/E Ratio
- KSCP N/A
- SHLT N/A
- Revenue Growth
- KSCP N/A
- SHLT N/A
- 52 Week Low
- KSCP $2.52
- SHLT $1.85
- 52 Week High
- KSCP $31.50
- SHLT $7.96
- Technical
- Relative Strength Index (RSI)
- KSCP 19.17
- SHLT 41.26
- Support Level
- KSCP $3.78
- SHLT $1.90
- Resistance Level
- KSCP $4.25
- SHLT $2.54
- Average True Range (ATR)
- KSCP 0.41
- SHLT 0.26
- MACD
- KSCP 0.05
- SHLT -0.04
- Stochastic Oscillator
- KSCP 11.19
- SHLT 33.33
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.